Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Phenoxymethylpenicillin potassium
Athlone Laboratories Ltd
J01CE; J01CE02
Phenoxymethylpenicillin potassium
250 milligram(s)
Tablet
Product subject to prescription which may not be renewed (A)
Beta-lactamase sensitive penicillins; phenoxymethylpenicillin
Marketed
1987-07-24
0007 CCF21-007 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have further questions, please ask your doctor or pharmacist (chemist). This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side-effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1) What Kopen 250mg Tablets are and what they are used for 2) What you need to know before you take Kopen 250mg Tablets 3) How to take Kopen 250mg Tablets 4) Possible side effects 5) How to store Kopen 250mg Tablets 6) Contents of the pack and other information 1. WHAT KOPEN 250MG TABLETS ARE AND WHAT THEY ARE USED FOR The name of your medicine is Kopen 250mg Tablets. These tablets are dispensed by the pharmacist. Kopen 250mg Tablets contains Phenoxymethylpenicillin, which is a penicillin antibiotic, used to kill bacteria that cause infections in your body. Kopen 250mg Tablets are used to: treat bacterial infections of the ear, throat, respiratory tract, skin and soft tissues prevent infections such as: infection occurring in patients without a spleen or in patients with sickle cell disease (a blood disorder) rheumatic fever 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE KOPEN 250MG TABLETS DO NOT TAKE KOPEN 250MG TABLETS IF YOU: are allergic to Phenoxymethylpenicillin, or any of the other ingredients of this medicine listed in section 6. have ever had a bad reaction or allergic reaction to any penicillin-type antibiotics including ampicillin or cephalosporin antibiotics have ever had a skin rash or swelling of the face or neck or shortness of breath when taking any antibiotic WARNINGS AND PRECAUTIONS TALK TO YOUR DOCTOR OR PHARMACIST BEFORE TAKING KOPEN Read the complete document
Health Products Regulatory Authority 11 June 2021 CRN00CD9D Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Kopen 250mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 250 mg of phenoxymethylpenicillin (as phenoxymethylpenicillin potassium). Each tablet also contains 94.6mg of lactose. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablets Circular white tablets approximately 10.5 mm in diameter, embossed ‘Pen 250’. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For use in the treatment of infections caused by penicillin-sensitive gram positive bacteria and in particular Staphylococci, Pneumococci, Gonococci and Haemolytic Streptococci. Phenoxymethylpenicillin is also indicated for: • Prophylaxis of pneumococcal infection (e.g. in asplenia and in patients with sickle cell disease). • Prophylaxis of rheumatic fever. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY ADULTS: 250mg or 500mg every six hours depending on the severity of the condition. ELDERLY: As for adults RENAL IMPAIRMENT: The dosage should be reduced if renal function is markedly impaired. PROPHYLACTIC USE: • Pneumococcal infection (e.g. asplenia) Adults: 500mg every 12 hours Children 6 - 12 years: 250mg every 12 hours Children <5 years: 125mg every 12 hours • Rheumatic fever 250mg twice daily is recommended for long term prophylaxis or rheumatic fever. CHILDREN INFANTS (UP TO 1 YEAR): Tablets are not usually given to this age group. A liquid medicine is available. Children 1 – 5 years: 125mg 6 hourly Children 6 – 12 years: 250mg 6 hourly Method of Administration For instructions on reconstitution on the medicinal product before administration, see section 6.6. Health Products Regulatory Authority 11 June 2021 CRN00CD9D Page 2 of 6 For oral administration only Ideally, each dose should be given half an hour before (or at least three hours after) a meal. T Read the complete document